Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
Clinical trial NCT04604067 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04604067
- Sponsor
- Swiss Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2026-07-30
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.